Endocrine Disorders in Childhood Cancer Survivors Treated with Haemopoietic Stem Cell Transplantation
Abstract
:1. Introduction
2. Growth Failure and Growth Hormone Deficiency
3. Disorder of the Gonadal and Reproductive Function
Males
Females
4. Thyroid Disease
4.1. Subclinical Hypothyroidism
4.2. Overt Hypothyroidism
4.3. Autoimmune Thyroid Disease
4.4. Thyroid Malignancies
5. Abnormalities of the Hypothalamic–Pituitary–Adrenal Axis
6. Impaired Bone Mineral Density
7. The Metabolic Syndrome
8. Conclusions
Author Contributions
Conflicts of Interest
References
- Thomas, E.D.; Clift, R.A.; Hersman, J.; Sanders, J.E.; Stewart, P.; Buckner, C.D.; Fefer, A.; McGuffin, R.; Smith, J.W.; Storb, R. Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1982, 8, 817–821. [Google Scholar] [CrossRef]
- Brauner, R.; Adan, L.; Souberbielle, J.C.; Esperou, H.; Michon, J.; Devergie, A.; Gluckman, E.; Zucker, J.M. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J. Pediatr. 1997, 130, 785–792. [Google Scholar]
- Armenian, S.H.; Sun, C.L.; Mills, G.; Teh, J.B.; Francisco, L.; Durand, J.B.; Wong, F.L.; Forman, S.J.; Bhatia, S. Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation. Biol. Blood Marrow Transpl. 2010, 16, 1138–1144. [Google Scholar]
- Baker, K.S.; Ness, K.K.; Weisdorf, D.; Francisco, L.; Sun, C.-L.; Forman, S.; Bhatia, S. Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: A report from the Bone Marrow Transplant Survivor Study. Leukemia 2010, 24, 2039–2047. [Google Scholar] [CrossRef]
- Chow, E.J.; Simmons, J.H.; Roth, C.L.; Baker, K.S.; Paul, A.; Sanders, J.E.; Friedman, D.L. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukaemia treated with total body irradation. Biol. Blood Marrow Transpl. 2011, 16, 1674–1681. [Google Scholar]
- Felicetti, F.; Manicone, R.; Corrias, A.; Manieri, C.; Biasin, E.; Bini, I.; Boccuzzi, G.; Brignardello, E. Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: A retrospective study from a single institution. J. Cancer Res. Clin. Oncol. 2011, 137, 1343–1348. [Google Scholar] [CrossRef]
- Kauppila, M.; Koskinen, P.; Irjala, K.; Remes, K.; Viikari, J. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults. Bone Marrow Transpl. 1998, 22, 331–337. [Google Scholar]
- Shalitin, S.; Phillip, M.; Stein, J.; Goshen, Y.; Carmi, D.; Yaniv, I. Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transpl. 2006, 37, 1109–1117. [Google Scholar] [CrossRef]
- Dvorak, C.C.; Gracia, C.R.; Sanders, J.E.; Cheng, E.Y.; Baker, K.S.; Pulsipher, M.A.; Petryk, A. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. Biol. Blood Marrow Transpl. 2011, 17, 1725–1738. [Google Scholar] [CrossRef]
- Socié, G.; Salooja, N.; Cohen, A.; Rovelli, A.; Carreras, E.; Locasciulli, A.; Korthof, E.; Weis, J.; Levy, V.; Tichelli, A. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003, 101, 3373–3385. [Google Scholar] [CrossRef]
- Darzy, K.H.; Shalet, S.M. Hypopituitarism following radiotherapy revisited. Endocr. Dev. 2009, 15, 1–24. [Google Scholar] [CrossRef]
- Brauner, R.; Czernichow, P.; Rappaport, R. Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J. Pediatr. 1986, 108, 332. [Google Scholar]
- Cohen, A.; Rovelli, A.; Bakker, B.; Uderzo, C.; van Lint, M.T.; Esperou, H.; Gaiero, A.; Leiper, A.D.; Dopfer, R.; Cahn, J.Y.; et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: A study by the Working Party for Late Effects-EBMT. Blood 1999, 93, 4109–4115. [Google Scholar]
- Ogilvy-Stuart, A.L.; Clark, D.J.; Wallace, W.H.; Gibson, B.E.; Stevens, R.F.; Shalet, S.M.; Donaldson, M.D. Endocrine deficit after fractionated total body irradiation. Arch. Dis. Child. 1992, 67, 1107–1110. [Google Scholar] [CrossRef]
- Sanders, J.E.; Guthrie, K.A.; Hoffmeister, P.A.; Woolfrey, A.E.; Carpenter, P.A.; Appelbaum, F.R. Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 2005, 105, 1348–1354. [Google Scholar]
- Giorgiani, G.; Bozzola, M.; Locatelli, F.; Picco, P.; Zecca, M.; Cisternino, M.; Dallorso, S.; Bonetti, F.; Dini, G.; Borrone, C. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995, 86, 825–831. [Google Scholar]
- Darzy, K.H. Radiation-induced hypopituitarism after cancer therapy: Who, how and when to test. Nat. Clin. Pract. Endocrinol. Metab. 2009, 5, 88–99. [Google Scholar] [CrossRef]
- Papadimitriou, A.; Urena, M.; Hamill, G.; Stanhope, R.; Leiper, A.D. Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation. Arch. Dis. Child. 1991, 66, 689–692. [Google Scholar] [CrossRef]
- Steffens, M.; Beauloye, V.; Brichard, B.; Robert, A.; Alexopoulou, O.; Vermylen, C.; Maiter, D. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL). Clin. Endocrinol. (Oxf.) 2008, 69, 819–827. [Google Scholar] [CrossRef]
- Leiper, A.D.; Stanhope, R.; Kitching, P.; Chessells, J.M. Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch. Dis. Child. 1987, 62, 1107–1112. [Google Scholar]
- Sklar, C.A.; Kim, T.H.; Ramsay, N.K. Testicular function following bone marrow transplantation performed during or after puberty. Cancer 1984, 53, 1498–1501. [Google Scholar] [CrossRef]
- Howell, S.J.; Shalet, S.M. Spermatogenesis after cancer treatment: Damage and recovery. J. Natl. Cancer Inst. Monogr. 2005, 34, 12–17. [Google Scholar] [CrossRef]
- Jacob, A.; Barker, H.; Goodman, A.; Holmes, J. Recovery of spermatogenesis following bone marrow transplantation. Bone Marrow Transpl. 1998, 22, 277–279. [Google Scholar]
- Sanders, J.E.; Hawley, J.; Levy, W.; Gooley, T.; Buckner, C.D.; Deeg, H.J.; Doney, K.; Storb, R.; Sullivan, K.; Witherspoon, R.; et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996, 87, 3045–3052. [Google Scholar]
- Rodriguez-Wallberg, K.A.; Oktay, K. Fertility preservation during cancer treatment: Clinical guidelines. Cancer Manag. Res. 2014, 6, 105–117. [Google Scholar]
- Traish, A.M.; Haider, A.; Doros, G.; Saad, F. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: An observational, long-term registry study. Int. J. Clin. Pract. 2014, 68, 314–329. [Google Scholar] [CrossRef]
- Irwig, M.S. Male hypogonadism and skeletal health. Curr. Opin. Endocrinol. Diabetes Obes. 2013, 20, 517–522. [Google Scholar] [CrossRef]
- Teinturier, C.; Hartmann, O.; Valteau-Couanet, D.; Benhamou, E.; Bougneres, P.F. Ovarian function after autologous bone marrow transplantation in childhood: High-dose busulfan is a major cause of ovarian failure. Bone Marrow Transpl. 1998, 22, 989–994. [Google Scholar]
- Beneventi, F.; Locatelli, E.; Giorgiani, G.; Zecca, M.; Locatelli, F.; Cavagnoli, C.; Simonetta, M.; Bariselli, S.; Negri, B.; Spinillo, A. Gonadal and uterine function in female survivors treated by chemotherapy, radiotherapy, and/or bone marrow transplantation for childhood malignant and non-malignant diseases. BJOG 2014, 121, 856–865. [Google Scholar] [CrossRef]
- Wallace, W.H.B.; Thomson, A.B.; Kelsey, T.W. The radiosensitivity of the human oocyte. Hum. Reprod. 2003, 18, 117–121. [Google Scholar] [CrossRef]
- Sanders, J.E.; Buckner, C.D.; Amos, D.; Levy, W.; Appelbaum, F.R.; Doney, K.; Storb, R.; Sullivan, K.M.; Witherspoon, R.P.; Thomas, E.D. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J. Clin. Oncol. 1988, 6, 813–818. [Google Scholar]
- Couto-Silva, A.C.; Trivin, C.; Thibaud, E.; Esperou, H.; Michon, J.; Brauner, R. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transpl. 2001, 28, 67–75. [Google Scholar] [CrossRef]
- Cohen, A.; Békássy, A.N.; Gaiero, A.; Faraci, M.; Zecca, S.; Tichelli, A.; Dini, G. Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transpl. 2008, 41, S43–S48. [Google Scholar] [CrossRef]
- Krawczuk-Rybak, M.; Leszczynska, E.; Poznanska, M.; Zelazowska-Rutkowska, B.; Wysocka, J. The progressive reduction in the ovarian reserve in young women after anticancer treatment. Horm. Metab. Res. 2013, 45, 813–819. [Google Scholar] [CrossRef]
- Bath, L.E.; Critchley, H.O.; Chambers, S.E.; Anderson, R.A.; Kelnar, C.J.; Wallace, W.H. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: Response to sex steroid replacement. Br. J. Obstet. Gynaecol. 1999, 106, 1265–1272. [Google Scholar] [CrossRef]
- Holm, K.; Nysom, K.; Brocks, V.; Hertz, H.; Jacobsen, N.; Müller, J. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood. Bone Marrow Transpl. 1999, 23, 259–263. [Google Scholar]
- Bailey, H.K.; Kappy, M.S.; Giller, R.H.; Gralla, J. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation. Pediatr. Blood Cancer 2008, 51, 405–409. [Google Scholar] [CrossRef]
- Sanders, J.E.; Hoffmeister, P.A.; Woolfrey, A.E.; Carpenter, P.A.; Storer, B.E.; Storb, R.F.; Appelbaum, F.R. Thyroid function following hematopoietic cell transplantation in children: 30 years’ experience. Blood 2009, 113, 306–308. [Google Scholar]
- Boulad, F.; Bromley, M.; Black, P.; Heller, G.; Sarafoglou, K.; Gillio, A.; Papadopoulos, E.; Sklar, C. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transpl. 1995, 15, 71–76. [Google Scholar]
- Ishiguro, H.; Yasuda, Y.; Tomita, Y.; Shinagawa, T.; Shimizu, T.; Morimoto, T.; Hattori, K.; Matsumoto, M.; Inoue, H.; Yabe, H.; et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J. Clin. Endocrinol. Metab. 2004, 89, 5981–5986. [Google Scholar] [CrossRef]
- Berger, C.; le-Gallo, B.; Donadieu, J.; Richard, O.; Devergie, A.; Galambrun, C.; Bordigoni, P.; Vilmer, E.; Plouvier, E.; Perel, Y.; et al. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transpl. 2005, 35, 991–995. [Google Scholar] [CrossRef]
- Rivas, M.; Santisteban, P. TSH-activated signaling pathways in thyroid tumorigenesis. Mol. Cell. Endocrinol. 2003, 213, 31–45. [Google Scholar]
- Berisso, G.A.; van Lint, M.T.; Bacigalupo, A.; Marmont, A.M. Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves’ disease. Bone Marrow Transpl. 1999, 23, 1091–1092. [Google Scholar]
- Vestergaard, T.R.; Juul, A.; Lausten-Thomsen, U.; Lausen, B.; Hjalgrim, H.; Kvist, T.K.; Andersen, E.W.; Schmiegelow, K. Duration of adrenal insufficiency during treatment for childhood acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol. 2011, 33, 442–449. [Google Scholar] [CrossRef]
- Benmiloud, S.; Steffens, M.; Beauloye, V.; de Wandeleer, A.; Devogelaer, J.-P.; Brichard, B.; Vermylen, C.; Maiter, D. Long-term effects on bone mineral density of different therapeutic schemes for acute lymphoblastic leukemia or non-Hodgkin lymphoma during childhood. Horm. Res. Padiatr. 2010, 74, 241–250. [Google Scholar] [CrossRef]
- Kaste, S.C.; Shidler, T.J.; Tong, X.; Srivastava, D.K.; Rochester, R.; Hudson, M.M.; Shearer, P.D.; Hale, G.A. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transpl. 2004, 33, 435–441. [Google Scholar] [CrossRef]
- Petryk, A.; Bergemann, T.L.; Polga, K.M.; Ulrich, K.J.; Raatz, S.K.; Brown, D.M.; Robison, L.L.; Baker, K.S. Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J. Clin. Endocrinol. Metab. 2006, 91, 899–905. [Google Scholar] [CrossRef]
- Petryk, A.; Polgreen, L.E.; Zhang, L.; Hodges, J.S.; Dengel, D.R.; Hoffmeister, P.A.; Steinberger, J.; Baker, K.S. Bone mineral deficits in recipients of hematopoietic cell transplantation: The impact of young age at transplant. Bone Marrow Transpl. 2014, 49, 258–263. [Google Scholar] [CrossRef]
- Frisk, P.; Arvidson, J.; Ljunggren, O.; Gustafsson, J. Decreased bone mineral density in young adults treated with SCT in childhood: The role of 25-hydroxyvitamin D. Bone Marrow Transpl. 2012, 47, 657–662. [Google Scholar]
- Scheven, B.A.; van der Veen, M.J.; Damen, C.A.; Lafeber, F.P.; van Rijn, H.J.; Bijlsma, J.W.; Duursma, S.A. Effects of methotrexate on human osteoblasts in vitro: Modulation by 1,25-dihydroxyvitamin D3. J. Bone Miner. Res. 1995, 10, 874–880. [Google Scholar]
- Baek, K.H.; Lee, W.Y.; Oh, K.W.; Kim, H.S.; Han, J.H.; Kang, M.I.; Cha, B.Y.; Lee, K.W.; Son, H.Y.; Kang, S.K.; et al. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: Impact on bone and mineral metabolism. J. Clin. Endocrinol. Metab. 2004, 89, 1246–1254. [Google Scholar]
- Polgreen, L.E.; Petryk, A.; Dietz, A.C.; Sinaiko, A.R.; Leisenring, W.; Goodman, P.; Steffen, L.M.; Perkins, J.L.; Dengel, D.R.; Baker, K.S.; et al. Modifiable risk factors associated with bone deficits in childhood cancer survivors. BMC Pediatr. 2012, 12, 40. [Google Scholar] [CrossRef]
- Ruble, K.; Hayat, M.J.; Stewart, K.J.; Chen, A.R. Bone mineral density after bone marrow transplantation in childhood: Measurement and associations. Biol. Blood Marrow Transpl. 2010, 16, 1451–1457. [Google Scholar] [CrossRef]
- Carpenter, P.A.; Hoffmeister, P.; Chesnut, C.H.; Storer, B.; Charuhas, P.M.; Woolfrey, A.E.; Sanders, J.E. Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol. Blood Marrow Transpl. 2007, 13, 683–690. [Google Scholar]
- Marini, J.C. Do bisphosphonates make children’s bones better or brittle? N. Engl. J. Med. 2003, 349, 423–426. [Google Scholar] [CrossRef]
- Alberti, K.G.; Zimmet, P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998, 15, 539–553. [Google Scholar] [CrossRef]
- Balkau, B.; Charles, M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetes Med. 1999, 16, 442–443. [Google Scholar] [CrossRef]
- Grundy, S.M.; Brewer, H.B.; Cleeman, J.I.; Smith, S.C.; Lenfant, C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109, 433–438. [Google Scholar] [CrossRef]
- Alberti, K.G.M.M.; Zimmet, P.; Shaw, J. The metabolic syndrome—A new worldwide definition. Lancet 2005, 366, 1059–1062. [Google Scholar] [CrossRef]
- Oudin, C.; Simeoni, M.-C.; Sirvent, N.; Contet, A.; Begu-Le Coroller, A.; Bordigoni, P.; Curtillet, C.; Poirée, M.; Thuret, I.; Play, B.; et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood 2011, 117, 4442–4448. [Google Scholar]
- Frisk, P.; Rössner, S.M.; Norgren, S.; Arvidson, J.; Gustafsson, J. Glucose metabolism and body composition in young adults treated with TBI during childhood. Bone Marrow Transpl. 2011, 46, 1303–1308. [Google Scholar] [CrossRef]
- Nysom, K.; Holm, K.; Michaelsen, K.F.; Hertz, H.; Jacobsen, N.; Müller, J.; Nysom, K.; Holm, K.; Michaelsen, K.F.; Hertz, H.; et al. Degree of fatness after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transpl. 2001, 27, 817–820. [Google Scholar] [CrossRef]
- Ruble, K.; Hayat, M.; Stewart, K.J.; Chen, A. Body composition after bone marrow transplantation in childhood. Oncol. Nurs. Forum 2012, 39, 186–192. [Google Scholar] [CrossRef]
- Couto-Silva, A.C.; Trivin, C.; Esperou, H.; Michon, J.; Fischer, A.; Brauner, R. Changes in height, weight and plasma leptin after bone marrow transplantation. Bone Marrow Transpl. 2000, 26, 1205–1210. [Google Scholar] [CrossRef]
- Chow, E.J.; Liu, W.; Srivastava, K.; Leisenring, W.M.; Hayashi, R.J.; Sklar, C.A.; Stovall, M.; Robison, L.L.; Baker, K.S. Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: A childhood cancer survivor study report. Pediatr. Blood Cancer 2013, 60, 110–115. [Google Scholar] [CrossRef]
- Kyle, U.G.; Chalandon, Y.; Miralbell, R.; Karsegard, V.L.; Hans, D.; Trombetti, A.; Rizzoli, R.; Helg, C.P.C.; Kyle, U.G.; Chalandon, Y.; et al. Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients. Bone Marrow Transpl. 2005, 35, 1171–1177. [Google Scholar] [CrossRef]
- Baker, K.S.; Ness, K.K.; Steinberger, J.; Carter, A.; Francisco, L.; Burns, L.J.; Sklar, C.; Forman, S.; Weisdorf, D.; Gurney, J.G.; et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: A report from the bone marrow transplantation survivor study. Blood 2007, 109, 1765–1772. [Google Scholar] [CrossRef]
- Majhail, N.S.; Challa, T.R.; Mulrooney, D.A.; Baker, K.S.; Burns, L.J. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transpl. 2009, 15, 1100–1107. [Google Scholar] [CrossRef]
- Hoffmeister, P.A.; Hingorani, S.R.; Storer, B.E.; Baker, K.S.; Sanders, J.E. Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. Biol. Blood Marrow Transpl. 2010, 16, 515–524. [Google Scholar] [CrossRef]
- Taskinen, M.; Saarinen-Pihkala, U.M.; Hovi, L.; Lipsanen-Nyman, M. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000, 356, 993–997. [Google Scholar] [CrossRef]
- Perkins, J.L.; Kunin-Batson, A.S.; Youngren, N.M.; Ness, K.K.; Ulrich, K.J.; Hansen, M.J.; Petryk, A.; Steinberger, J.; Anderson, F.S.; Baker, K.S. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr. Blood Cancer 2007, 49, 958–963. [Google Scholar] [CrossRef]
- Rajendran, R.; Abu, E.; Fadl, A.; Byrne, C.D. Late effects of childhood cancer treatment: Severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood total body irradiation. Diabetes Med. 2013, 30, e239–e242. [Google Scholar] [CrossRef]
- Mayson, S.E.; Parker, V.E.R.; Schutta, M.H.; Semple, R.K.; Rickels, M.R. Severe insulin resistance and hypertriglyceridemia after childhood total body irradiation. Endocr. Pract. 2013, 19, 51–58. [Google Scholar] [CrossRef]
- Meacham, L.R.; Sklar, C.A.; Li, S.; Liu, Q.; Gimpel, N.; Yasui, Y.; Whitton, J.A.; Stovall, M.; Robison, L.L.; Oeffinger, K.C. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: A report for the childhood cancer survivor study. Arch. Intern. Med. 2009, 169, 1381–1388. [Google Scholar] [CrossRef]
- Neville, K.A.; Cohn, R.J.; Steinbeck, K.S.; Johnston, K.; Walker, J.L. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: Prevalence and risk factors. J. Clin. Endocrinol. Metab. 2006, 91, 4401–4407. [Google Scholar] [CrossRef]
- Chemaitilly, W.; Boulad, F.; Oeffinger, K.C.; Sklar, C. Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: A pilot study. Bone Marrow Transpl. 2009, 44, 339–343. [Google Scholar] [CrossRef]
- Scottish Intercollegiate Guidelines Network (SIGN). Long Term Follow up of Survivors of Childhood Cancer. SIGN publication no. 132. March 2013. Available online: http://www.sign.ac.uk (accessed on 01/05/2014).
- Kavey, R.-E.W.; Allada, V.; Daniels, S.R.; Hayman, L.L.; McCrindle, B.W.; Newburger, J.W.; Parekh, R.S.; Steinberger, J. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; The Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention. Circulation 2006, 114, 2710–2738. [Google Scholar] [CrossRef]
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Share and Cite
Wei, C.; Albanese, A. Endocrine Disorders in Childhood Cancer Survivors Treated with Haemopoietic Stem Cell Transplantation. Children 2014, 1, 48-62. https://doi.org/10.3390/children1010048
Wei C, Albanese A. Endocrine Disorders in Childhood Cancer Survivors Treated with Haemopoietic Stem Cell Transplantation. Children. 2014; 1(1):48-62. https://doi.org/10.3390/children1010048
Chicago/Turabian StyleWei, Christina, and Assunta Albanese. 2014. "Endocrine Disorders in Childhood Cancer Survivors Treated with Haemopoietic Stem Cell Transplantation" Children 1, no. 1: 48-62. https://doi.org/10.3390/children1010048